Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Eur J Clin Nutr ; 73(9): 1316-1322, 2019 09.
Artículo en Inglés | MEDLINE | ID: mdl-30962515

RESUMEN

BACKGROUND/OBJECTIVES: Sulfites are additives commonly used in food and wine industries that are associated to adverse clinical effects such as headaches. The objective of this study is to investigate the possible association between sulfite concentration in wine and the occurrence of headaches in young adults. SUBJECTS/METHODS: Eighty volunteers, aged between 18 and 25 years, were evaluated. Sub-groups (with or without previous headaches related with wine) were created and volunteers were submitted to two wine tests (minimum and maximum sulfite concentration accordingly to weight). A questionnaire was handed out after the test regarding the presence or not of headaches, their main characteristics, as well as other symptoms associated. RESULTS: Subjects that refer a previous headache history upon wine ingestion presented a risk 2266 greater of developing headaches after wine ingestion with a greater sulfite concentration. Those that refer constant headaches related to wine ingestion previous to the test present a risk of 6232 times more of developing headaches compared to those who refer sporadic headaches related to wine consumption. CONCLUSIONS: In our group of subjects, sulfite concentration in wine is related to the risk of developing headaches in individuals who are susceptible to wine induced headaches.


Asunto(s)
Cefalea/epidemiología , Sulfitos/análisis , Vino/análisis , Adolescente , Adulto , Femenino , Humanos , Masculino , Estudios Prospectivos , Sulfitos/administración & dosificación , Sulfitos/efectos adversos , Adulto Joven
2.
Int J Neurosci ; 128(5): 472-476, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-29064737

RESUMEN

BACKGROUND: Illiteracy, high cerebrovascular risk and copies of APOE-ϵ4 are risk factors for Alzheimer's disease dementia (AD). We aimed to investigate the impacts of gender, education, coronary heart disease (CHD) risk and creatinine clearance variations, body mass index (BMI) and APOE haplotypes over the rates of cognitive and functional decline of AD in one year. METHODS: Consecutive outpatients with late-onset AD were assessed for gender, schooling, BMI and APOE haplotypes, variations in one year of creatinine clearance and Framingham projections of the 10-year absolute CHD risk, and prospective scores of the Mini-Mental State Examination (MMSE), the Clinical Dementia Rating Sum-of-Boxes (CDR-SOB), the Index of Independence in Activities of Daily Living (ADL) and Lawton's Scale for Instrumental Activities of Daily Living (IADL). RESULTS: For 191 patients, mean age at AD onset was 73.26 ± 6.4 years-old, earlier for APOE-ϵ4/ϵ4 carriers (p = 0.0039). For women, higher BMI led to improvements in CDR-SOB (ß = -0.091; p = 0.037) and MMSE (ß = 0.126; p = 0.017) scores, while increased creatinine clearance was associated with improvements in ADL (ß = 0.028; p = 0.012) and MMSE (ß = 0.043; p = 0.039) scores and higher schooling led to faster worsening of IADL (ß = -0.195; p = 0.022) scores. No variables impacted cognitive or functional decline for men, whereas copies of APOE-ϵ4 and the CHD risk had no significant effects whatsoever. CONCLUSIONS: Higher BMI and creatinine clearance are protective regarding cognitive and functional decline for women, whereas higher cognitive reserve may lead to faster decline in instrumental functionality. APOE haplotypes affected the age at AD onset, but not cognitive or functional decline.


Asunto(s)
Enfermedad de Alzheimer/complicaciones , Enfermedad de Alzheimer/genética , Apolipoproteína E4/genética , Trastornos del Conocimiento/etiología , Caracteres Sexuales , Anciano , Anciano de 80 o más Años , Índice de Masa Corporal , Enfermedades Cardiovasculares/complicaciones , Trastornos del Conocimiento/genética , Creatinina/metabolismo , Femenino , Haplotipos , Humanos , Modelos Lineales , Masculino , Escala del Estado Mental , Pacientes Ambulatorios , Factores de Riesgo
3.
Nutrire Rev. Soc. Bras. Aliment. Nutr ; 42: 1-6, Dec. 2017. ilus
Artículo en Inglés | LILACS | ID: biblio-881548

RESUMEN

Alzheimer's disease corresponds to 50­70% of all dementia syndromes, classified as a progressive neurodegenerative disease showing diffuse cortical atrophy with three stages of evolution: mild, moderate, and severe. Behavioral symptoms and memory loss are major manifestations of the disease. Non-pharmacological interventions are essential to improve the quality of life of these patients. Interdisciplinary assistance is essential throughout the disease course. Regarding nutrition for patients with Alzheimer's disease, weight loss and behavioral changes related to food are major objects of scientific study, as they trigger deterioration of the quality of life of patients and caregivers. Knowing which nutritional guidelines should be used helps in clinical decisions. The study of nutrition in dementia is, therefore, critical for patient management.


Asunto(s)
Humanos , Masculino , Femenino , Enfermedad de Alzheimer/dietoterapia , Trastornos de Deglución/dietoterapia , Suplementos Dietéticos/estadística & datos numéricos
4.
J Neurol Sci ; 359(1-2): 127-32, 2015 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-26671101

RESUMEN

Midlife cerebrovascular risk, low cognitive reserve and APOE4+ haplotypes are risk factors for Alzheimer's disease dementia (AD). We prospectively searched for factors that might be associated with yearly changes in caregiver burden, cognition, basic and instrumental functionality in 193 consecutive outpatients with late-onset AD, namely gender, APOE haplotypes, schooling, age at AD onset, marital status, depression, cerebrovascular risk factors, serum TSH levels, cognitive and physical activities, and treatment with cholinesterase inhibitors or anti-psychotics, while also investigating associations between APOE haplotypes and patient participation in cognitive or physical activities. Higher education led to greater declines in instrumental functionality, whereas increases in body mass index were associated with rises in basic functionality and cognitive test scores. Established cerebrovascular risk factors had no independent effects over cognitive or functional change, but their combinations led to cognitive improvement, possibly related to enhanced cerebral perfusion in late life. Cholinesterase inhibitors improved caregiver burden. Enhanced instrumental functionality and steeper cognitive decline by the use of anti-psychotics might be attributed to improved behavioural symptoms and neuropsychiatric side effects, respectively. Each copy of APOE-ε4 (ß=-0.102) led to cumulative decreased participation in physical activities (ρ=0.015). These results might impact public health policies and the interpretation of clinical trials for AD.


Asunto(s)
Actividades Cotidianas , Enfermedad de Alzheimer/complicaciones , Trastornos del Conocimiento/etiología , Actividad Motora/fisiología , Actividades Cotidianas/psicología , Anciano , Anciano de 80 o más Años , Enfermedad de Alzheimer/genética , Antipsicóticos/efectos adversos , Apolipoproteínas E/genética , Índice de Masa Corporal , Brasil , Estudios de Cohortes , Escolaridad , Femenino , Genotipo , Humanos , Masculino , Pruebas Neuropsicológicas , Evaluación de Resultado en la Atención de Salud , Escalas de Valoración Psiquiátrica , Factores de Riesgo
5.
Curr Gerontol Geriatr Res ; 2012: 983056, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22645608

RESUMEN

An increasing proportion of older adults with Alzheimer's disease or other dementias are now surviving to more advanced stages of the illness. Advanced dementia is associated with feeding problems, including difficulty in swallowing and respiratory diseases. Patients become incompetent to make decisions. As a result, complex situations may arise in which physicians and families decide whether artificial nutrition and hydration (ANH) is likely to be beneficial for the patient. The objective of this paper is to present methods for evaluating the nutritional status of patients with severe dementia as well as measures for the treatment of nutritional disorders, the use of vitamin and mineral supplementation, and indications for ANH and pharmacological therapy.

6.
Nutr J ; 10: 98, 2011 Sep 26.
Artículo en Inglés | MEDLINE | ID: mdl-21943331

RESUMEN

BACKGROUND: Weight loss in patients with Alzheimer's disease (AD) is a common clinical manifestation that may have clinical significance. OBJECTIVES: To evaluate if there is a difference between nutrition education and oral nutritional supplementation on nutritional status in patients with AD. METHODS: A randomized, prospective 6-month study which enrolled 90 subjects with probable AD aged 65 years or older divided into 3 groups: Control Group (CG) [n = 27], Education Group (EG) [n = 25], which participated in an education program and Supplementation Group (SG) [n = 26], which received two daily servings of oral nutritional supplementation. Subjects were assessed for anthropometric data (weight, height, BMI, TSF, AC and AMC), biochemical data (total protein, albumin, and total lymphocyte count), CDR (Clinical Dementia Rating), MMSE (Mini-mental state examination), as well as dependence during meals. RESULTS: The SG showed a significant improvement in the following anthropometric measurements: weight (H calc = 22.12, p =< 0.001), BMI (H calc = 22.12, p =< 0.001), AC (H calc = 12.99, p =< 0.002), and AMC (H calc = 8.67, p =< 0.013) compared to the CG and EG. BMI of the EG was significantly greater compared to the CG. There were significant changes in total protein (H calc = 6.17, p =< 0.046), and total lymphocyte count in the SG compared to the other groups (H cal = 7.94, p = 0.019). CONCLUSION: Oral nutritional supplementation is more effective compared to nutrition education in improving nutritional status.


Asunto(s)
Enfermedad de Alzheimer/complicaciones , Suplementos Dietéticos , Educación en Salud , Estado Nutricional , Anciano , Enfermedad de Alzheimer/dietoterapia , Demencia , Femenino , Humanos , Masculino , Terapia Nutricional , Estudios Prospectivos , Pérdida de Peso
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...